Gynecologic Oncology Group: all 188 studies

Page 1 of 2. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial CancerRecruitingNCT01000259
• Ribociclib and Letrozole Treatment in Ovarian CancerActive, not recruitingNCT03673124Phase 2Results posted
• Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial CancerStatus unknownNCT02065687Phase 2/3Results posted
• Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT01720173Phase 2Results posted
• Dalantercept in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT01642082Phase 2Results posted
• Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the VulvaStatus unknownNCT01595061Phase 2Results posted
• Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by SurgeryTerminatedNCT01533207Phase 3Results posted
• Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian CancerTerminatedNCT01275664Not applicableResults posted
• Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT01267253Phase 2Results posted
• Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT01266460Phase 2Results posted
• Nintedanib in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT01225887Phase 2Results posted
• Trebananib in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT01210222Phase 2Results posted
• EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT01118052Phase 2Results posted
• Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT01039207Phase 2Results posted
• Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial CancerStatus unknownNCT00942357Phase 3Results posted
• A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00939809Phase 2Results posted
• Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00888173Phase 2Results posted
• OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete RemissionCompletedNCT00857545Phase 2Results posted
• Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00820898Phase 2Results posted
• Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial CancerStatus unknownNCT00807768Phase 3Results posted
• Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00691301Phase 2Results posted
• A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CarcinomaCompletedNCT00671788Phase 2Results posted
• Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial CancerTerminatedNCT00577317Phase 3Results posted
• AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerTerminatedNCT00574951Phase 2Results posted
• Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube CancerCompletedNCT00569673Phase 2Results posted
• Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial HyperplasiaTerminatedNCT00503581Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00499252Phase 2Results posted
• Cetuximab in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00499031Phase 2Results posted
• Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00459290Phase 2Results posted
• Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian CancerCompletedNCT00445887Phase 2Results posted
• Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00407758Phase 2Results posted
• Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the UterusCompletedNCT00379145Phase 2Results posted
• ABI-007 in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00309959Phase 2Results posted
• Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both OvariesCompletedNCT00305695Phase 2Results posted
• Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine CancerCompletedNCT00114218Phase 2Results posted
• Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00114166Phase 2Results posted
• Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine CancerCompletedNCT00112489Phase 2Results posted
• Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00101192Phase 2Results posted
• Topotecan in Treating Women With Persistent or Recurrent Cervical CancerCompletedNCT00087126Phase 2Results posted
• Celecoxib in Treating Patients With Cervical Intraepithelial NeoplasiaCompletedNCT00081263Phase 2Results posted
• Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical CancerTerminatedNCT00070317Not applicableResults posted
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the VulvaCompletedNCT00068406Phase 2Results posted
• Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the CervixCompletedNCT00064077Phase 3Results posted
• Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine CorpusCompletedNCT00064025Phase 2Results posted
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00011986Phase 3Results posted
• Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial CancerStatus unknownNCT00006903Phase 2Results posted
• Paclitaxel in Treating Patients With Ovarian Stromal CancerCompletedNCT00006227Phase 2Results posted
• Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00006011Phase 3Results posted
• Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic NeoplasiaCompletedNCT00003702Phase 3Results posted
• Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian CancerCompletedNCT00003644Phase 3Results posted
• Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the CervixCompletedNCT00003377Phase 1Results posted
• Abemaciclib and Letrozole to Treat Endometrial CancerActive, not recruitingNCT04393285Phase 2
• Pazopanib for Treating Uterine LeiomyosarcomaWithdrawnNCT02378142Phase 2
• Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node DissectionStatus unknownNCT01500512
• Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing ChemotherapyWithdrawnNCT01492920Phase 3
• EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT01489371Phase 1
• Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199WithdrawnNCT01445275
• Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and LymphadenectomyCompletedNCT01406769Phase 2
• Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal CancerStatus unknownNCT01372787
• Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerStatus unknownNCT01366183
• Biomarkers in Blood and Tissue Samples From Patients With Uterine CancerCompletedNCT01344837
• Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical CancerStatus unknownNCT01295502Phase 1
• Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT01295489
• TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerCompletedNCT01294293Phase 1
• Prognostic Biomarkers in Patients With Endometrial CancerCompletedNCT01208467
• Biomarkers in Samples From Patients With Endometrial CancerWithdrawnNCT01199250
• Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial CancerCompletedNCT01198171
• Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT01164735
• Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial CancerStatus unknownNCT01150682
• Incidence of Cancer in Women at Increased Genetic Risk of Ovarian CancerCompletedNCT01139957
• Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial CancerStatus unknownNCT01119573
• Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical CancerCompletedNCT01098630
• Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyCompletedNCT01080521
• Studying Biomarkers in Blood Samples From Patients With Invasive Cervical CancerStatus unknownNCT01074424
• Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182Status unknownNCT01074398
• Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerStatus unknownNCT00958698Not applicable
• Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar CancerStatus unknownNCT00956670Not applicable
• Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation CarriersWithdrawnNCT00899145
• YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving ChemotherapyTerminatedNCT00899093
• Radiation Therapy or Surgery in Treating Patients With Previously Untreated Vulva Cancer With Positive Groin Lymph NodesCompletedNCT00898352Phase 3
• Study of Pap Smears From Patients Enrolled on Clinical Trial GOG-171Status unknownNCT00898144
• Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation CarriersStatus unknownNCT00897455
• Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
• Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00814086Phase 1
• Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerStatus unknownNCT00719303Phase 3
• Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete RemissionWithdrawnNCT00693342Phase 3
• Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial CancerCompletedNCT00575952Phase 1
• Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line ChemotherapyWithdrawnNCT00551265Not applicable
• Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic TumorsCompletedNCT00521118Phase 2
• Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172WithdrawnNCT00477867Not applicable
• Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesCompletedNCT00460356
• Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or CarboplatinWithdrawnNCT00369954Phase 2
• Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerCompletedNCT00352300Phase 1
• Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00276796Phase 2
• Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic MassStatus unknownNCT00238342Not applicable
• Pelvic Exenteration in Treating Patients With Recurrent Cervical CancerCompletedNCT00217633Phase 2
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedNCT00104910Phase 1
• Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine LeiomyosarcomaCompletedNCT00101127Phase 2
• Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar PregnancyTerminatedNCT00096187Phase 2
• Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the CervixCompletedNCT00087113Phase 2

← Gynecologic Oncology Group overview and focus areas